Publicaciones en colaboración con investigadores/as de Harvard Medical School (29)

2024

  1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

    Nature Communications

2023

  1. Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

    Journal of the National Cancer Institute, Vol. 115, Núm. 9, pp. 1050-1059

2022

  1. Obesity is Associated With Increased Risk of Crohn's disease, but not Ulcerative Colitis: A Pooled Analysis of Five Prospective Cohort Studies

    Clinical Gastroenterology and Hepatology, Vol. 20, Núm. 5, pp. 1048-1058

2021

  1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (Nature Communications, (2021), 12, 1, (2349), 10.1038/s41467-021-22446-z)

    Nature Communications

  2. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

    Nature Communications, Vol. 12, Núm. 1

2020

  1. A nutrient-wide association study for risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition and the Netherlands Cohort Study

    European Journal of Nutrition, Vol. 59, Núm. 7, pp. 2929-2937

2019

  1. Educational note: Paradoxical collider effect in the analysis of non-communicable disease epidemiological data: A reproducible illustration and web application

    International Journal of Epidemiology, Vol. 48, Núm. 2, pp. 640-653

  2. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium

    International Journal of Cancer, Vol. 145, Núm. 1, pp. 58-69

  3. Secular trends in stillbirth by maternal socioeconomic status in Spain 2007-15: A population-based study of 4 million births

    European Journal of Public Health, Vol. 29, Núm. 6, pp. 1043-1048

2018

  1. Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk: Results from the EPIC cohort

    Cancer Epidemiology Biomarkers and Prevention, Vol. 27, Núm. 7, pp. 790-804

  2. Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels: Results from the EPIC cohort

    International Journal of Cancer, Vol. 142, Núm. 7, pp. 1355-1360

  3. Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation

    International Journal of Cancer, Vol. 143, Núm. 3, pp. 515-526

2017

  1. Correlates of circulating ovarian cancer early detection markers and their contribution to discrimination of early detection models: results from the EPIC cohort

    Journal of Ovarian Research, Vol. 10, Núm. 1, pp. 1-14

  2. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women

    Fertility and Sterility, Vol. 107, Núm. 4, pp. 1012-1022.e2

  3. Human adipose tissue levels of persistent organic pollutants and metabolic syndrome components: Combining a cross-sectional with a 10-year longitudinal study using a multi-pollutant approach

    Environment International, Vol. 104, pp. 48-57

  4. Rare Variant Analysis of Human and Rodent Obesity Genes in Individuals with Severe Childhood Obesity

    Scientific Reports, Vol. 7, Núm. 1

2016

  1. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease

    Science Translational Medicine, Vol. 8, Núm. 341

  2. A prospective evaluation of early detection biomarkers for ovarian cancer in the European EPIC cohort

    Clinical Cancer Research, Vol. 22, Núm. 18, pp. 4664-4675

  3. A protocol for developing, disseminating, and implementing a core outcome set for pre-eclampsia

    Pregnancy Hypertension, Vol. 6, Núm. 4, pp. 274-278

  4. Cross-cancer genome-wide analysis of lung, ovary, breast, prostate, and colorectal cancer reveals novel pleiotropic associations

    Cancer Research, Vol. 76, Núm. 17, pp. 5103-5114